Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy

NCT03789786 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2023-10-13

No results posted yet for this study

Summary

Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for clinicians and families. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families during medical decision making.

Conditions

  • Cerebral Palsy

Interventions

DIAGNOSTIC_TEST

Gait and Motion Analysis

Gait and motion analysis is comprised of 3-dimensional kinematics and kinetics, electromyography, energy expenditure, and physical exam (range of motion, strength, spasticity, etc.)

DIAGNOSTIC_TEST

Gross Motor Function Measure (GMFM)

Gross Motor Function Measure (GMFM) is an assessment used to evaluate gross motor function over time in individuals with cerebral palsy. The assessment is comprised of movement activities like standing, walking, running, and jumping

BEHAVIORAL

Surveys

Six surveys are used to assess function, activity, participation, pain, quality of life, and treatment history

Sponsors & Collaborators

  • Shriners Hospitals for Children

    collaborator OTHER
  • Gillette Children's Specialty Healthcare

    lead OTHER

Principal Investigators

  • Michael Schwartz, PhD · Gillette Children's Specialty Healthcare

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03789786 on ClinicalTrials.gov